Goldschmidt H - Search Results

1

Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma.

Auel B, Goldschmidt H, Geer T, Moehler TM, Platzbecker U, Naumann R, Blau I, Hänel M, Knauf W, Nückel H, Salwender HJ, Scheid C, Weisel K, Gorschlüter M, Glasmacher A, Schmidt-Wolf IG; German Refractory Myeloma Study Group. Auel B, et al. Among authors: goldschmidt h. Indian J Hematol Blood Transfus. 2012 Jun;28(2):67-76. doi: 10.1007/s12288-011-0103-1. Epub 2011 Aug 18. Indian J Hematol Blood Transfus. 2012. PMID: 23730012 Free PMC article.

2

Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.

Neben K, Mytilineos J, Moehler TM, Preiss A, Kraemer A, Ho AD, Opelz G, Goldschmidt H. Neben K, et al. Among authors: goldschmidt h. Blood. 2002 Sep 15;100(6):2263-5. Blood. 2002. PMID: 12200397 Free article. Clinical Trial.

3

Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.

Neben K, Moehler T, Benner A, Kraemer A, Egerer G, Ho AD, Goldschmidt H. Neben K, et al. Among authors: goldschmidt h. Clin Cancer Res. 2002 Nov;8(11):3377-82. Clin Cancer Res. 2002. PMID: 12429624 Clinical Trial.

4

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.

Witzens M, Moehler T, Neben K, Fruehauf S, Hartschuh W, Ho AD, Goldschmidt H. Witzens M, et al. Among authors: goldschmidt h. Ann Hematol. 2004 Jul;83(7):467-70. doi: 10.1007/s00277-003-0804-0. Epub 2003 Nov 19. Ann Hematol. 2004. PMID: 14625789

5

Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial.

Glasmacher A, Goldschmidt H, Mezger J, Haferlach T, Schmidt-Wolf IG, Gieseler F; Phase II trial. Glasmacher A, et al. Among authors: goldschmidt h. Haematologica. 2004 Mar;89(3):371-3. Haematologica. 2004. PMID: 15020285 Clinical Trial.

6

Combined effect of recombinant CD19 x CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma.

Schlenzka J, Moehler TM, Kipriyanov SM, Kornacker M, Benner A, Bähre A, Stassar MJ, Schäfer HJ, Little M, Goldschmidt H, Cochlovius B. Schlenzka J, et al. Among authors: goldschmidt h. Anticancer Drugs. 2004 Oct;15(9):915-9. doi: 10.1097/00001813-200410000-00013. Anticancer Drugs. 2004. PMID: 15457133

7

A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma.

Glasmacher A, Hahn C, Hoffmann F, Naumann R, Goldschmidt H, von Lilienfeld-Toal M, Orlopp K, Schmidt-Wolf I, Gorschlüter M. Glasmacher A, et al. Among authors: goldschmidt h. Br J Haematol. 2006 Mar;132(5):584-93. doi: 10.1111/j.1365-2141.2005.05914.x. Br J Haematol. 2006. PMID: 16445831 Free article. Review.

8

Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.

Klaus J, Herrmann D, Breitkreutz I, Hegenbart U, Mazitschek U, Egerer G, Cremer FW, Lowenthal RM, Huesing J, Fruehauf S, Moehler T, Ho AD, Goldschmidt H. Klaus J, et al. Among authors: goldschmidt h. Eur J Haematol. 2007 Jan;78(1):21-8. doi: 10.1111/j.0902-4441.2006.t01-1-EJH2895.x. Epub 2006 Sep 28. Eur J Haematol. 2007. PMID: 17042762

9

The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.

Raab MS, Breitkreutz I, Hundemer M, Benner A, Klaus J, Hegenbart U, Moehler T, Ho AD, Zeier M, Goldschmidt H. Raab MS, et al. Among authors: goldschmidt h. Haematologica. 2006 Nov;91(11):1555-8. Haematologica. 2006. PMID: 17082013

10

Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.

Hillengass J, Wasser K, Delorme S, Kiessling F, Zechmann C, Benner A, Kauczor HU, Ho AD, Goldschmidt H, Moehler TM. Hillengass J, et al. Among authors: goldschmidt h. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):475-81. doi: 10.1158/1078-0432.CCR-06-0061. Clin Cancer Res. 2007. PMID: 17255268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Search Page

Filters